ACTRN12610000520033
Completed
Phase 1
A randomised placebo controlled crossover trial to evaluate the effects of different doses of taurocholic acid in a suppository on gastrointestinal hormone secretion and appetite in healthy humans.
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Type 2 diabetes mellitus
- Sponsor
- Royal Adelaide Hospital
- Enrollment
- 12
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Haemoglobin \> 135 g/
Exclusion Criteria
- •Medications affecting gut function
- •Alcohol intake \>20g daily or cigarette smoking
- •Significant gastrointestinal disease or surgery
- •Impaired liver or renal function
- •Blood donation within 3 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A randomised placebo controlled crossover trial to evaluate the effects of intrajejunal taurocholic acid on gastrointestinal hormone secretion and glycaemia in response to intrajejunal glucose infusion in healthy humans for the future design of treatments for type 2 diabetes mellitusACTRN12612001213831Royal Adelaide Hospital14
Completed
Not Applicable
Protease supplementation and delayed onset muscle soreness (DOMS)ACTRN12612000467831niversity of Otago30
Completed
Phase 2
Effects of Hydroxycitrate (HCA) on intestinal glucose absorption and incretin releaseType 2 diabetes mellitusMetabolic and Endocrine - DiabetesACTRN12615000088549niversity of Adelaide20
Completed
Not Applicable
A trial to evaluate the effects of a D-xylose preload, with or without sitagliptin, on incretin hormone secretion, gastric emptying, and postprandial glycaemia in patients with type 2 diabetes mellitus.Type 2 diabetes mellitusMetabolic and Endocrine - DiabetesACTRN12612001131842Royal Adelaide Hospital12
Completed
Not Applicable
Gutsy Gum and HeartburACTRN12612000973819niversity of Otago20